Smith & Nephew (SNN) Liabilities and Shareholders Equity (2009 - 2025)

Smith & Nephew (SNN) posted quarterly Liabilities and Shareholders Equity of $10.5 billion for Q4 2025, up 0.99% year-on-year from $10.4 billion in Q4 2024, and down 2.2% on a QoQ basis from $10.7 billion in Q2 2025.

Smith & Nephew (SNN) Liabilities and Shareholders Equity (2009 - 2025) Analysis & Trends

Smith & Nephew (SNN) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $10.5 billion the latest figure, recorded in Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 0.99% year-over-year to $10.5 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $42.0 billion (up 100.92% YoY) and the FY2025 annual result came in at $10.5 billion, up 0.99% from the prior year.
  • Liabilities and Shareholders Equity retreated to $10.5 billion in Q4 2025 per SNN's latest filing, from $10.7 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for SNN reached as high as $10.7 billion in Q2 2025 and fell as low as $12.0 million in Q4 2022.
  • A 5-year average of $6.0 billion and a median of $10.4 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity tumbled 40.0% — and 2024, when it soared 57422.22%.
  • Year by year, Liabilities and Shareholders Equity stood at $20.0 million in 2021, then slumped by 40.0% to $12.0 million in 2022, then jumped by 50.0% to $18.0 million in 2023, then surged by 57422.22% to $10.4 billion in 2024, then grew by 0.99% to $10.5 billion in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $10.5 billion, $10.7 billion, and $10.4 billion for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 10.74 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 10.46 Bn
Jun 28, 2025 10.69 Bn
Dec 31, 2024 10.35 Bn
Jun 29, 2024 10.54 Bn
Dec 31, 2023 18.00 Mn
Dec 31, 2022 12.00 Mn
Dec 31, 2021 20.00 Mn
Dec 31, 2020 9.00 Mn
Jun 30, 2020 9.54 Bn
Dec 31, 2019 7.00 Mn
Jun 29, 2019 8.95 Bn
Dec 31, 2018 34.00 Mn
Jun 30, 2018 7.71 Bn
Dec 31, 2017 21.00 Mn
Dec 31, 2016 7.34 Bn
Dec 31, 2015 7.17 Bn
Jun 30, 2015 7.22 Bn
Dec 31, 2014 7.31 Bn
Sep 30, 2014 7.65 Bn
Jun 28, 2014 7.74 Bn